Natalizumab in Inclusion Body Myositis (IBM)
- First Posted Date
- 2015-06-29
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Phoenix Neurological Associates, LTD
- Target Recruit Count
- 6
- Registration Number
- NCT02483845
- Locations
- 🇺🇸
Phoenix Neurological Insitutute, Phoenix, Arizona, United States
Determining the Safety of L-serine in ALS
- First Posted Date
- 2013-04-19
- Last Posted Date
- 2015-07-30
- Lead Sponsor
- Phoenix Neurological Associates, LTD
- Target Recruit Count
- 20
- Registration Number
- NCT01835782
- Locations
- 🇺🇸
Phoenix Neurological Associates, Phoenix, Arizona, United States
🇺🇸Forbes Norris MDA/ALS Research Center, San Francisco, California, United States
Dermatomyositis and Polymyositis Registry
- Conditions
- DermatomyositisPolymyositis
- First Posted Date
- 2012-07-10
- Last Posted Date
- 2015-11-06
- Lead Sponsor
- Phoenix Neurological Associates, LTD
- Target Recruit Count
- 100
- Registration Number
- NCT01637064
- Locations
- 🇺🇸
PNA Center for Neurological Research, Phoenix, Arizona, United States
🇺🇸Ara Dikranian MD, San Diego, California, United States
🇺🇸Neurology INC, Columbia, Missouri, United States
Safety Study of High Doses of Zinc in ALS Patients
- First Posted Date
- 2010-12-13
- Last Posted Date
- 2012-03-12
- Lead Sponsor
- Phoenix Neurological Associates, LTD
- Target Recruit Count
- 10
- Registration Number
- NCT01259050
- Locations
- 🇺🇸
Phoenix Neurological Associates, Phoenix, Arizona, United States
Memantine Therapy in Amyotrophic Lateral Sclerosis
- First Posted Date
- 2009-11-25
- Last Posted Date
- 2009-11-25
- Lead Sponsor
- Phoenix Neurological Associates, LTD
- Target Recruit Count
- 20
- Registration Number
- NCT01020331
- Locations
- 🇺🇸
Phoenix Neurological Associates, LTD, Phoenix, Arizona, United States
Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)
Phase 1
Completed
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- First Posted Date
- 2009-06-12
- Last Posted Date
- 2012-11-30
- Lead Sponsor
- Phoenix Neurological Associates, LTD
- Target Recruit Count
- 28
- Registration Number
- NCT00919555
- Locations
- 🇺🇸
Phoenix Neurological Associates, LTD, Phoenix, Arizona, United States
Lithium in Inclusion Body Myositis (IBM)
Completed
- Conditions
- Inclusion Body Myositis
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2010-02-26
- Lead Sponsor
- Phoenix Neurological Associates, LTD
- Target Recruit Count
- 20
- Registration Number
- NCT00917956
- Locations
- 🇺🇸
Phoenix Neurological Associates, LTD, Phoenix, Arizona, United States